Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Soluble amyloid beta-protein is increased in frontotemporal dementia with tau gene mutations.

Journal of Alzheimer's disease : JAD - 1 Feb 2004

Vitali Antonella, Piccini Alessandra, Borghi Roberta, Fornaro Pantaleo, Siedlak Sandra L, Smith Mark A, Gambetti Pierluigi, Ghetti Bernardino, Tabaton Massimo

Abstract excerpt

The relationship between senile plaques and neurofibrillary tangles, the main pathologic lesions of Alzheimer's disease, is not completely understood. We addressed this issue examining the type and amount of amyloid beta-protein (Abeta) associated with the soluble and insoluble tissue fractions in the frontal cortex of 8 cases with frontotemporal dementia with parkinsonism caused by mutations of the Tau gene...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Dementia
Share to Frontal Lobe

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunoenzyme Techniques

Share to Neurofibrillary Tangles

Share to Plaque, Amyloid

Share to tau Proteins

Share to Tauopathies

Share to Temporal Lobe

Source

Identifiers

PMID: 15004327
DOI: 10.3233/jad-2004-6106

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Soluble amyloid beta-protein is increased in frontotemporal dementia with tau gene mutations.PMID 15004327Read ↗

Selective Deposition of Mutant Tau in the FTDP-17 Brain Affected by the P301L MutationSemantic proximity Read ↗

Comparison of extent of tau pathology in patients with frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17), frontotemporal lobar degeneration with Pick bodies and early onset Alzheimer's disease.Semantic proximity Read ↗

The neuropathology of frontotemporal lobar degeneration with respect to the cytological and biochemical characteristics of tau protein.Semantic proximity Read ↗

Tau protein as a differential biomarker of tauopathies.Semantic proximity Read ↗

Neurodegeneration and Alzheimer's disease: the lesson from tauopathies.Semantic proximity Read ↗

Alzheimer's disease: beta-Amyloid protein and tau.Semantic proximity Read ↗

[Molecular analysis of tau deposited in the FTDP-17 brain].Semantic proximity Read ↗

Loss of brain tau defines novel sporadic and familial tauopathies with frontotemporal dementiaSemantic proximity Read ↗

Beta-amlyoid 1-42 and tau-protein in cerebrospinal fluid of patients with Parkinson's disease dementia.Semantic proximity Read ↗

Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.Semantic proximity Read ↗

Genetics and neurobiology of frontotemporal lobar degeneration.Semantic proximity Read ↗

Decreased beta-amyloid peptide42 in cerebrospinal fluid of patients with progressive supranuclear palsy and corticobasal degeneration.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.